What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine Candidates

Adria Cimino, The Motley Fool
·4-min read
What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine Candidates

December will be a crucial month for both Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE). Earlier this week, Moderna requested Emergency Use Authorization (EUA) for its coronavirus vaccine candidate. Pfizer and its partner BioNTech (NASDAQ: BNTX) made their request about ten days earlier.